Literature DB >> 10459151

Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia.

H F Seow1, N M Mahomed, J W Mak, M A Riddell, F Li, D A Anderson.   

Abstract

The prevalence of antibodies to hepatitis E virus (HEV) has been examined in many countries, but such studies have generally been limited to majority populations such as those represented in healthy blood donors or cross sections of urban populations. Due to its major route of enteric transmission, large differences in HEV prevalence might be expected between populations in the same country but with different living conditions. Using an ELISA based on GST-ORF2.1 antigen, the prevalence of IgG-class antibodies to HEV was examined in three distinct populations in Malaysia: the normal (urban) blood donor population and two aboriginal communities located at Betau, Pahang and Parit Tanjung, Perak. IgG anti-HEV was detected in 45 (44%) of 102 samples from Betau and 15 (50%) of 30 samples from Parit Tanjung, compared to only 2 (2%) of 100 normal blood donors. The distribution of sample ELISA reactivities was also consistent with ongoing sporadic infection in the aboriginal communities, while there was no significant relationship between HEV exposure and age, sex, or malaria infection. The high prevalence of antibodies to HEV in the two aboriginal communities indicates that this group of people are at high risk of exposure to HEV compared to the general blood donors, and the results suggest that studies of HEV seroprevalence within countries must take into account the possibility of widely varying infection rates between populations with marked differences in living conditions. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459151     DOI: 10.1002/(sici)1096-9071(199910)59:2<164::aid-jmv7>3.0.co;2-j

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

Review 1.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

Review 2.  Hepatitis E vaccines: progress and prospects.

Authors:  Harald Claus Worm; Gerhard Wirnsberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

4.  Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Authors:  Claudia Lamarca Vitral; Mônica da Silva-Nunes; Marcelo Alves Pinto; Jaqueline Mendes de Oliveira; Ana Maria Coimbra Gaspar; Rebeca Cristina Costa Pereira; Marcelo Urbano Ferreira
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

5.  Serological Evidence of Hepatitis E Virus (HEV) Infection Among Ruminant Farmworkers: A Retrospective Study from Malaysia.

Authors:  Li Ping Wong; Sun Tee Tay; Kek Heng Chua; Xiang Ting Goh; Haridah Alias; Zizheng Zheng; Qinjian Zhao; Ting Wu; Ningshao Xia; Zhijian Hu; Yulan Lin
Journal:  Infect Drug Resist       Date:  2022-09-19       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.